Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 67 entries
Sorted by: Best Match Show Resources per page
Evaluation of French-language internet sites dealing with multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical

Guéguen A, Maillart E, Gallice T, Allaf B.
PMID: 28607728
Mult Scler J Exp Transl Clin. 2016 Jun 15;2:2055217316652419. doi: 10.1177/2055217316652419. eCollection 2016.

BACKGROUND: Information available on the internet has changed patient-neurologist relationships. Its evaluation for multiple sclerosis is only partial, regardless of the language used.OBJECTIVE: We aim to evaluate the content quality and ranking indexes of French-language sites dealing with multiple...

Cite
Guéguen A, Maillart E, Gallice T, et al. Evaluation of French-language internet sites dealing with multiple sclerosis. Mult Scler J Exp Transl Clin. 2016;2:2055217316652419doi: 10.1177/2055217316652419.
Guéguen, A., Maillart, E., Gallice, T., & Allaf, B. (2016). Evaluation of French-language internet sites dealing with multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical, 22055217316652419. https://doi.org/10.1177/2055217316652419
Guéguen, Antoine, et al. "Evaluation of French-language internet sites dealing with multiple sclerosis." Multiple sclerosis journal - experimental, translational and clinical vol. 2 (2016): 2055217316652419. doi: https://doi.org/10.1177/2055217316652419
Guéguen A, Maillart E, Gallice T, Allaf B. Evaluation of French-language internet sites dealing with multiple sclerosis. Mult Scler J Exp Transl Clin. 2016 Jun 15;2:2055217316652419. doi: 10.1177/2055217316652419. eCollection 2016. PMID: 28607728; PMCID: PMC5433325.
Copy Download .nbib Format: NLM
Antiproliferative Effect of Rottlerin on Sk-Mel-28 Melanoma Cells.

Evidence-based complementary and alternative medicine : eCAM

Daveri E, Valacchi G, Romagnoli R, Maellaro E, Maioli E.
PMID: 26161122
Evid Based Complement Alternat Med. 2015;2015:545838. doi: 10.1155/2015/545838. Epub 2015 May 28.

Melanoma is the most aggressive and chemoresistant form of skin cancer. Mutated, constitutively active B-RAF is believed to play a crucial role, although the selective B-RAF inhibition has shown poor clinical success, since phenomena of resistance usually occur, likely...

Cite
Daveri E, Valacchi G, Romagnoli R, et al. Antiproliferative Effect of Rottlerin on Sk-Mel-28 Melanoma Cells. Evid Based Complement Alternat Med. 2015;2015:545838doi: 10.1155/2015/545838.
Daveri, E., Valacchi, G., Romagnoli, R., Maellaro, E., & Maioli, E. (2015). Antiproliferative Effect of Rottlerin on Sk-Mel-28 Melanoma Cells. Evidence-based complementary and alternative medicine : eCAM, 2015545838. https://doi.org/10.1155/2015/545838
Daveri, Elena, et al. "Antiproliferative Effect of Rottlerin on Sk-Mel-28 Melanoma Cells." Evidence-based complementary and alternative medicine : eCAM vol. 2015 (2015): 545838. doi: https://doi.org/10.1155/2015/545838
Daveri E, Valacchi G, Romagnoli R, Maellaro E, Maioli E. Antiproliferative Effect of Rottlerin on Sk-Mel-28 Melanoma Cells. Evid Based Complement Alternat Med. 2015;2015:545838. doi: 10.1155/2015/545838. Epub 2015 May 28. PMID: 26161122; PMCID: PMC4464680.
Copy Download .nbib Format: NLM
Broad-spectrum β-lactams in obese non-critically ill patients.

Nutrition & diabetes

Hites M, Taccone FS, Wolff F, Maillart E, Beumier M, Surin R, Cotton F, Jacobs F.
PMID: 24956136
Nutr Diabetes. 2014 Jun 23;4:e119. doi: 10.1038/nutd.2014.15.

OBJECTIVES: Obesity may alter the pharmacokinetics of β-lactams. The goal of this study was to evaluate if and why serum concentrations are inadequate when standard β-lactam regimens are administered to obese, non-critically ill patients.SUBJECTS AND METHODS: During first year,...

Cite
Hites M, Taccone FS, Wolff F, et al. Broad-spectrum β-lactams in obese non-critically ill patients. Nutr Diabetes. 2014;4:e119doi: 10.1038/nutd.2014.15.
Hites, M., Taccone, F. S., Wolff, F., Maillart, E., Beumier, M., Surin, R., Cotton, F., & Jacobs, F. (2014). Broad-spectrum β-lactams in obese non-critically ill patients. Nutrition & diabetes, 4e119. https://doi.org/10.1038/nutd.2014.15
Hites, M, et al. "Broad-spectrum β-lactams in obese non-critically ill patients." Nutrition & diabetes vol. 4 (2014): e119. doi: https://doi.org/10.1038/nutd.2014.15
Hites M, Taccone FS, Wolff F, Maillart E, Beumier M, Surin R, Cotton F, Jacobs F. Broad-spectrum β-lactams in obese non-critically ill patients. Nutr Diabetes. 2014 Jun 23;4:e119. doi: 10.1038/nutd.2014.15. PMID: 24956136; PMCID: PMC4079925.
Copy Download .nbib Format: NLM
Territorial vulnerability evaluation in tiber watershed.

Environmental monitoring and assessment

Mennella VG, Borghi P, Macellari E, Porceddu PR.
PMID: 24193313
Environ Monit Assess. 1996 Jun;41(2):183-200. doi: 10.1007/BF00394343.

By now it has become a widespread, consistent practice in the European Union to consider very carefully and to regard as fundamental the basic needs of man, such as health and safety, in relation to all productive activities which...

Cite
Mennella VG, Borghi P, Macellari E, et al. Territorial vulnerability evaluation in tiber watershed. Environ Monit Assess. 1996;41(2):183-200doi: 10.1007/BF00394343.
Mennella, V. G., Borghi, P., Macellari, E., & Porceddu, P. R. (1996). Territorial vulnerability evaluation in tiber watershed. Environmental monitoring and assessment, 41(2), 183-200. https://doi.org/10.1007/BF00394343
Mennella, V G, et al. "Territorial vulnerability evaluation in tiber watershed." Environmental monitoring and assessment vol. 41,2 (1996): 183-200. doi: https://doi.org/10.1007/BF00394343
Mennella VG, Borghi P, Macellari E, Porceddu PR. Territorial vulnerability evaluation in tiber watershed. Environ Monit Assess. 1996 Jun;41(2):183-200. doi: 10.1007/BF00394343. PMID: 24193313.
Copy Download .nbib Format: NLM
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.

Annals of oncology : official journal of the European Society for Medical Oncology

Aparicio T, Bouché O, Taieb J, Maillard E, Kirscher S, Etienne PL, Faroux R, Khemissa Akouz F, El Hajbi F, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Paillaud E, Retornaz F, François E, Bedenne L.
PMID: 29718089
Ann Oncol. 2018 Nov 01;29(11):2270. doi: 10.1093/annonc/mdx808.

No abstract available.

Cite
Aparicio T, Bouché O, Taieb J, et al. Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results. Ann Oncol. 2018;29(11):2270doi: 10.1093/annonc/mdx808.
Aparicio, T., Bouché, O., Taieb, J., Maillard, E., Kirscher, S., Etienne, P. L., Faroux, R., Khemissa Akouz, F., El Hajbi, F., Locher, C., Rinaldi, Y., Lecomte, T., Lavau-Denes, S., Baconnier, M., Oden-Gangloff, A., Genet, D., Paillaud, E., Retornaz, F., François, E., Bedenne, L. (2018). Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results. Annals of oncology : official journal of the European Society for Medical Oncology, 29(11), 2270. https://doi.org/10.1093/annonc/mdx808
Aparicio, T, et al. "Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results." Annals of oncology : official journal of the European Society for Medical Oncology vol. 29,11 (2018): 2270. doi: https://doi.org/10.1093/annonc/mdx808
Aparicio T, Bouché O, Taieb J, Maillard E, Kirscher S, Etienne PL, Faroux R, Khemissa Akouz F, El Hajbi F, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Paillaud E, Retornaz F, François E, Bedenne L. Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results. Ann Oncol. 2018 Nov 01;29(11):2270. doi: 10.1093/annonc/mdx808. PMID: 29718089; PMCID: PMC6290877.
Copy Download .nbib Format: NLM
Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma.

Biomedical optics express

Rizzo R, Alvaro M, Danz N, Napione L, Descrovi E, Schmieder S, Sinibaldi A, Rana S, Chandrawati R, Munzert P, Schubert T, Maillart E, Anopchenko A, Rivolo P, Mascioletti A, Förster E, Sonntag F, Stevens MM, Bussolino F, Michelotti F.
PMID: 29552391
Biomed Opt Express. 2018 Jan 08;9(2):529-542. doi: 10.1364/BOE.9.000529. eCollection 2018 Feb 01.

Quantitative detection of angiogenic biomarkers provides a powerful tool to diagnose cancers in early stages and to follow its progression during therapy. Conventional tests require trained personnel, dedicated laboratory equipment and are generally time-consuming. Herein, we propose our developed...

Cite
Rizzo R, Alvaro M, Danz N, et al. Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma. Biomed Opt Express. 2018;9(2):529-542doi: 10.1364/BOE.9.000529.
Rizzo, R., Alvaro, M., Danz, N., Napione, L., Descrovi, E., Schmieder, S., Sinibaldi, A., Rana, S., Chandrawati, R., Munzert, P., Schubert, T., Maillart, E., Anopchenko, A., Rivolo, P., Mascioletti, A., Förster, E., Sonntag, F., Stevens, M. M., Bussolino, F., & Michelotti, F. (2018). Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma. Biomedical optics express, 9(2), 529-542. https://doi.org/10.1364/BOE.9.000529
Rizzo, Riccardo, et al. "Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma." Biomedical optics express vol. 9,2 (2018): 529-542. doi: https://doi.org/10.1364/BOE.9.000529
Rizzo R, Alvaro M, Danz N, Napione L, Descrovi E, Schmieder S, Sinibaldi A, Rana S, Chandrawati R, Munzert P, Schubert T, Maillart E, Anopchenko A, Rivolo P, Mascioletti A, Förster E, Sonntag F, Stevens MM, Bussolino F, Michelotti F. Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma. Biomed Opt Express. 2018 Jan 08;9(2):529-542. doi: 10.1364/BOE.9.000529. eCollection 2018 Feb 01. PMID: 29552391; PMCID: PMC5854056.
Copy Download .nbib Format: NLM
Accounting for Bacterial Overlap Between Raw Water Communities and Contaminating Sources Improves the Accuracy of Signature-Based Microbial Source Tracking.

Frontiers in microbiology

Hägglund M, Bäckman S, Macellaro A, Lindgren P, Borgmästars E, Jacobsson K, Dryselius R, Stenberg P, Sjödin A, Forsman M, Ahlinder J.
PMID: 30356843
Front Microbiol. 2018 Oct 02;9:2364. doi: 10.3389/fmicb.2018.02364. eCollection 2018.

Microbial source tracking (MST) analysis is essential to identifying and mitigating the fecal pollution of water resources. The signature-based MST method uses a library of sequences to identify contaminants based on operational taxonomic units (OTUs) that are unique to...

Cite
Hägglund M, Bäckman S, Macellaro A, et al. Accounting for Bacterial Overlap Between Raw Water Communities and Contaminating Sources Improves the Accuracy of Signature-Based Microbial Source Tracking. Front Microbiol. 2018;9:2364doi: 10.3389/fmicb.2018.02364.
Hägglund, M., Bäckman, S., Macellaro, A., Lindgren, P., Borgmästars, E., Jacobsson, K., Dryselius, R., Stenberg, P., Sjödin, A., Forsman, M., & Ahlinder, J. (2018). Accounting for Bacterial Overlap Between Raw Water Communities and Contaminating Sources Improves the Accuracy of Signature-Based Microbial Source Tracking. Frontiers in microbiology, 92364. https://doi.org/10.3389/fmicb.2018.02364
Hägglund, Moa, et al. "Accounting for Bacterial Overlap Between Raw Water Communities and Contaminating Sources Improves the Accuracy of Signature-Based Microbial Source Tracking." Frontiers in microbiology vol. 9 (2018): 2364. doi: https://doi.org/10.3389/fmicb.2018.02364
Hägglund M, Bäckman S, Macellaro A, Lindgren P, Borgmästars E, Jacobsson K, Dryselius R, Stenberg P, Sjödin A, Forsman M, Ahlinder J. Accounting for Bacterial Overlap Between Raw Water Communities and Contaminating Sources Improves the Accuracy of Signature-Based Microbial Source Tracking. Front Microbiol. 2018 Oct 02;9:2364. doi: 10.3389/fmicb.2018.02364. eCollection 2018. PMID: 30356843; PMCID: PMC6190859.
Copy Download .nbib Format: NLM
Comparison of Two Highly Discriminatory Typing Methods to Analyze .

Frontiers in microbiology

Garcia-Rubio R, Escribano P, Gomez A, Guinea J, Mellado E.
PMID: 30079058
Front Microbiol. 2018 Jul 20;9:1626. doi: 10.3389/fmicb.2018.01626. eCollection 2018.

No abstract available.

Cite
Garcia-Rubio R, Escribano P, Gomez A, et al. Comparison of Two Highly Discriminatory Typing Methods to Analyze . Front Microbiol. 2018;9:1626doi: 10.3389/fmicb.2018.01626.
Garcia-Rubio, R., Escribano, P., Gomez, A., Guinea, J., & Mellado, E. (2018). Comparison of Two Highly Discriminatory Typing Methods to Analyze . Frontiers in microbiology, 91626. https://doi.org/10.3389/fmicb.2018.01626
Garcia-Rubio, Rocio, et al. "Comparison of Two Highly Discriminatory Typing Methods to Analyze ." Frontiers in microbiology vol. 9 (2018): 1626. doi: https://doi.org/10.3389/fmicb.2018.01626
Garcia-Rubio R, Escribano P, Gomez A, Guinea J, Mellado E. Comparison of Two Highly Discriminatory Typing Methods to Analyze . Front Microbiol. 2018 Jul 20;9:1626. doi: 10.3389/fmicb.2018.01626. eCollection 2018. PMID: 30079058; PMCID: PMC6062602.
Copy Download .nbib Format: NLM
Unveiling Signatures of Topological Phases in Open Kitaev Chains and Ladders.

Nanomaterials (Basel, Switzerland)

Maiellaro A, Romeo F, Perroni CA, Cataudella V, Citro R.
PMID: 31216764
Nanomaterials (Basel). 2019 Jun 18;9(6). doi: 10.3390/nano9060894.

In this work, the general problem of the characterization of the topological phase of an open quantum system is addressed. In particular, we study the topological properties of Kitaev chains and ladders under the perturbing effect of a current...

Cite
Maiellaro A, Romeo F, Perroni CA, et al. Unveiling Signatures of Topological Phases in Open Kitaev Chains and Ladders. Nanomaterials (Basel). 2019;9(6)doi: 10.3390/nano9060894.
Maiellaro, A., Romeo, F., Perroni, C. A., Cataudella, V., & Citro, R. (2019). Unveiling Signatures of Topological Phases in Open Kitaev Chains and Ladders. Nanomaterials (Basel, Switzerland), 9(6), . https://doi.org/10.3390/nano9060894
Maiellaro, Alfonso, et al. "Unveiling Signatures of Topological Phases in Open Kitaev Chains and Ladders." Nanomaterials (Basel, Switzerland) vol. 9,6 (2019). doi: https://doi.org/10.3390/nano9060894
Maiellaro A, Romeo F, Perroni CA, Cataudella V, Citro R. Unveiling Signatures of Topological Phases in Open Kitaev Chains and Ladders. Nanomaterials (Basel). 2019 Jun 18;9(6). doi: 10.3390/nano9060894. PMID: 31216764; PMCID: PMC6630905.
Copy Download .nbib Format: NLM
Similarities and differences upon binding of naturally occurring Δ.

Pharmacological research

Raïch I, Rivas-Santisteban R, Lillo A, Lillo J, Reyes-Resina I, Nadal X, Ferreiro-Vera C, de Medina VS, Majellaro M, Sotelo E, Navarro G, Franco R.
PMID: 34758399
Pharmacol Res. 2021 Dec;174:105970. doi: 10.1016/j.phrs.2021.105970. Epub 2021 Nov 07.

We have here assessed, using Δ

Cite
Raïch I, Rivas-Santisteban R, Lillo A, et al. Similarities and differences upon binding of naturally occurring Δ. Pharmacol Res. 2021;174:105970doi: 10.1016/j.phrs.2021.105970.
Raïch, I., Rivas-Santisteban, R., Lillo, A., Lillo, J., Reyes-Resina, I., Nadal, X., Ferreiro-Vera, C., de Medina, V. S., Majellaro, M., Sotelo, E., Navarro, G., & Franco, R. (2021). Similarities and differences upon binding of naturally occurring Δ. Pharmacological research, 174105970. https://doi.org/10.1016/j.phrs.2021.105970
Raïch, Iu, et al. "Similarities and differences upon binding of naturally occurring Δ." Pharmacological research vol. 174 (2021): 105970. doi: https://doi.org/10.1016/j.phrs.2021.105970
Raïch I, Rivas-Santisteban R, Lillo A, Lillo J, Reyes-Resina I, Nadal X, Ferreiro-Vera C, de Medina VS, Majellaro M, Sotelo E, Navarro G, Franco R. Similarities and differences upon binding of naturally occurring Δ. Pharmacol Res. 2021 Dec;174:105970. doi: 10.1016/j.phrs.2021.105970. Epub 2021 Nov 07. PMID: 34758399.
Copy Download .nbib Format: NLM
Chronic necrotizing aspergillosis: A new risk with teriflunomide in multiple sclerosis patients?.

Revue neurologique

Pourcher V, Yeung J, Le Pimpec-Barthes F, Maillart E, Gibault L, Boussouar S.
PMID: 34579947
Rev Neurol (Paris). 2021 Sep 24; doi: 10.1016/j.neurol.2021.06.012. Epub 2021 Sep 24.

No abstract available.

Cite
Pourcher V, Yeung J, Le Pimpec-Barthes F, et al. Chronic necrotizing aspergillosis: A new risk with teriflunomide in multiple sclerosis patients?. Rev Neurol (Paris). 2021;doi: 10.1016/j.neurol.2021.06.012.
Pourcher, V., Yeung, J., Le Pimpec-Barthes, F., Maillart, E., Gibault, L., & Boussouar, S. (2021). Chronic necrotizing aspergillosis: A new risk with teriflunomide in multiple sclerosis patients?. Revue neurologique, . https://doi.org/10.1016/j.neurol.2021.06.012
Pourcher, Valérie, et al. "Chronic necrotizing aspergillosis: A new risk with teriflunomide in multiple sclerosis patients?." Revue neurologique vol. (2021). doi: https://doi.org/10.1016/j.neurol.2021.06.012
Pourcher V, Yeung J, Le Pimpec-Barthes F, Maillart E, Gibault L, Boussouar S. Chronic necrotizing aspergillosis: A new risk with teriflunomide in multiple sclerosis patients?. Rev Neurol (Paris). 2021 Sep 24; doi: 10.1016/j.neurol.2021.06.012. Epub 2021 Sep 24. PMID: 34579947.
Copy Download .nbib Format: NLM
Prognosis Factors and Outcomes of Neuro-ophthalmologic Sarcoidosis.

Ocular immunology and inflammation

Leclercq M, Sené T, Chapelon-Abric C, Desbois AC, Domont F, Maillart E, Shor N, Vignal-Clermont C, Guéguen A, Bodaghi B, Cacoub P, Touitou V, Saadoun D.
PMID: 33166196
Ocul Immunol Inflamm. 2020 Nov 09;1-8. doi: 10.1080/09273948.2020.1834585. Epub 2020 Nov 09.

No abstract available.

Cite
Leclercq M, Sené T, Chapelon-Abric C, et al. Prognosis Factors and Outcomes of Neuro-ophthalmologic Sarcoidosis. Ocul Immunol Inflamm. 2020;1-8doi: 10.1080/09273948.2020.1834585.
Leclercq, M., Sené, T., Chapelon-Abric, C., Desbois, A. C., Domont, F., Maillart, E., Shor, N., Vignal-Clermont, C., Guéguen, A., Bodaghi, B., Cacoub, P., Touitou, V., & Saadoun, D. (2020). Prognosis Factors and Outcomes of Neuro-ophthalmologic Sarcoidosis. Ocular immunology and inflammation, 1-8. https://doi.org/10.1080/09273948.2020.1834585
Leclercq, Mathilde, et al. "Prognosis Factors and Outcomes of Neuro-ophthalmologic Sarcoidosis." Ocular immunology and inflammation vol. (2020): 1-8. doi: https://doi.org/10.1080/09273948.2020.1834585
Leclercq M, Sené T, Chapelon-Abric C, Desbois AC, Domont F, Maillart E, Shor N, Vignal-Clermont C, Guéguen A, Bodaghi B, Cacoub P, Touitou V, Saadoun D. Prognosis Factors and Outcomes of Neuro-ophthalmologic Sarcoidosis. Ocul Immunol Inflamm. 2020 Nov 09;1-8. doi: 10.1080/09273948.2020.1834585. Epub 2020 Nov 09. PMID: 33166196.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 67 entries